Ryan P. Westergaard

5.7k citations

101 papers · 1.9k indexed · h-index 27

Impact in

Infectious Diseases top 2%
- HIV/AIDS Research and Interventions
Virology top 5%
- HIV Research and Treatment

Papers in ⓘ

Hepatology 17
- Hepatitis C virus research 17
Infectious Diseases 37
- HIV/AIDS Research and Interventions 30

Co-authors: Gregory D. Kirk (16 shared papers)Shruti H. Mehta (7 shared papers)Anne C. Spaulding (1 shared paper)Timothy Flanigan (1 shared paper)Elizabeth A. Jacobs (7 shared papers)Shawnika J. Hull (6 shared papers)Karli R. Hochstatter (12 shared papers)Joshua A. Barocas (3 shared papers)
Journals: Harm Reduction Journal (6 papers)JAMA Network Open (5 papers)AIDS and Behavior (5 papers)Open Forum Infectious Diseases (5 papers)Clinical Infectious Diseases (4 papers)
Partner nations: United States United Kingdom Malaysia

In The Last Decade

Ryan P. Westergaard

91 papers receiving 1.9k citations

Peers

Countries citing papers authored by Ryan P. Westergaard

Since Specialization

Citations

This map shows the geographic impact of Ryan P. Westergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan P. Westergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan P. Westergaard more than expected).

Fields of papers citing papers by Ryan P. Westergaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan P. Westergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan P. Westergaard. The network helps show where Ryan P. Westergaard may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryan P. Westergaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryan P. Westergaard Line = papers co-authored together Ryan P. Westergaard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study Harm Reduction Journal ·Joshua A. Barocas, Meghan B. Brennan, Shawnika J. Hull, Scott Stokes, John Fangman, Ryan P. Westergaard	2014	103
2	Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention AIDS and Behavior ·Karli R. Hochstatter, Wajiha Z. Akhtar, Sarah Dietz, Klaren Pe‐Romashko, David H. Gustafson, Dhavan V. Shah, Sarah Krechel, Cameron Liebert, R A Miller, Nabila El‐Bassel, Ryan P. Westergaard	2020	93
3	Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users AIDS ·Ryan P. Westergaard, Timothy Hess, Jacquie Astemborski, Shruti H. Mehta, Gregory D. Kirk	2013	84
4	Loss of Taste and Smell as Distinguishing Symptoms of Coronavirus Disease 2019 Clinical Infectious Diseases ·Patrick Dawson, Elizabeth M. Rabold, Rebecca L. Laws, Erin E. Conners, Radhika Gharpure, Sherry Yin, Sean Buono, Trivikram Dasu, Sanjib Bhattacharyya, Ryan P. Westergaard, Ian W. Pray, Dongni Ye, Scott A. Nabity, Jacqueline E. Tate, Hannah L. Kirking	2020	81
5	HIV among persons incarcerated in the USA Current Opinion in Infectious Diseases ·Ryan P. Westergaard, Anne C. Spaulding, Timothy Flanigan	2012	79
6	Provider and clinic‐level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers Journal of the International AIDS Society ·Ryan P. Westergaard, Bridget K. Ambrose, Shruti H. Mehta, Gregory D. Kirk	2012	76
7	Incarceration Predicts Virologic Failure for HIV-Infected Injection Drug Users Receiving Antiretroviral Therapy Clinical Infectious Diseases ·Ryan P. Westergaard, Gregory D. Kirk, D. R. Richesson, Noya Galai, Shruti H. Mehta	2011	64
8	Prospective study of a proactive palliative care rounding intervention in a medical ICU Intensive Care Medicine ·Nicholas Braus, Toby C. Campbell, Kristine L. Kwekkeboom, Susan A. Ferguson, Carrie Harvey, Anna Krupp, Tara Lohmeier, Michael D. Repplinger, Ryan P. Westergaard, Elizabeth A. Jacobs, Kate Ford Roberts, William J. Ehlenbach	2015	56
9	Acceptability of a mobile health intervention to enhance HIV care coordination for patients with substance use disorders Addiction Science & Clinical Practice ·Ryan P. Westergaard, Andrew Genz, Kristen Panico, Pamela J. Surkan, Jeanne Keruly, Heidi E. Hutton, Larry W. Chang, Gregory D. Kirk	2017	49
10	Shedding of infectious SARS-CoV-2 despite vaccination PLoS Pathogens ·Kasen K. Riemersma, Luis A. Haddock, Nancy A. Wilson, Nicholas R. Minor, Jens C. Eickhoff, Brittany Grogan, Amanda Kita-Yarbro, Peter Halfmann, Hannah E. Segaloff, Anna Kocharian, Kelsey R. Florek, Ryan P. Westergaard, Allen Bateman, Gunnar E. Jeppson, Yoshihiro Kawaoka, David H. O’Connor, Thomas C. Friedrich, Katarina M. Grande	2022	45
11	Racial/Ethnic Differences in Trust in Health Care: HIV Conspiracy Beliefs and Vaccine Research Participation Journal of General Internal Medicine ·Ryan P. Westergaard, Mary Catherine Beach, Somnath Saha, Elizabeth A. Jacobs	2013	42
12	COVID-19 Outbreak at an Overnight Summer School Retreat ― Wisconsin, July–August 2020 MMWR Morbidity and Mortality Weekly Report ·Ian W. Pray, Suzanne Gibbons-Burgener, Avi Z. Rosenberg, Devlin Cole, Shmuel Borenstein, Allen Bateman, Eric Pevzner, Ryan P. Westergaard	2020	40
13	Capturing illicit drug use where and when it happens: an ecological momentary assessment of the social, physical and activity environment of using versus craving illicit drugs Addiction ·Beth Linas, Carl A. Latkin, Ryan P. Westergaard, Larry W. Chang, Robert C. Bollinger, Andrew Genz, Gregory D. Kirk	2014	37
14	The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care Health & Justice ·Karli R. Hochstatter, Lauren J. Stockman, Ryan Holzmacher, James L. Greer, David W. Seal, Quinton A Taylor, Emma Gill, Ryan P. Westergaard	2017	36
15	Bridging the gap between conventional and alternative medicine. PubMed ·Bruce Barrett, Lucille Marchand, Jo C. Scheder, Diane Appelbaum, Michael Chapman, Carola Jacobs, Ryan P. Westergaard, Nicole E. St Clair	2000	36
16	The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial Trials ·David H. Gustafson, Gina Landucci, Fiona McTavish, Rachel Kornfield, Roberta Ann Johnson, Marie‐Louise Mares, Ryan P. Westergaard, Andrew Quanbeck, Esra Alagöz, Klaren Pe‐Romashko, Chantelle Thomas, Dhavan V. Shah	2016	34
17	Factors Influencing Risk for COVID-19 Exposure Among Young Adults Aged 18–23 Years — Winnebago County, Wisconsin, March–July 2020 MMWR Morbidity and Mortality Weekly Report ·Rebecca F. Wilson, Andrea J. Sharma, Sarahjean Schluechtermann, Dustin W. Currie, Joan M. Mangan, Brian Kaplan, Kimberly Goffard, Julia E. Salomón, Sue Casteel, Ashley Mukasa, Niki Euhardy, Andrew Ruiz, Greg Bautista, Erika J Bailey, Ryan P. Westergaard, Douglas Gieryn	2020	34
18	Ethical Issues in mHealth Research Involving Persons Living with HIV/AIDS and Substance Abuse AIDS Research and Treatment ·Alain Labrique, Gregory D. Kirk, Ryan P. Westergaard, Maria W. Merritt	2013	32
19	Early onset inhalant use and risk for opiate initiation by young adulthood☆ Drug and Alcohol Dependence ·Carla L. Storr, Ryan P. Westergaard, James C. Anthony	2005	32
20	Uptake and Acceptability of Information and Communication Technology in a Community-Based Cohort of People Who Inject Drugs: Implications for Mobile Health Interventions JMIR mhealth and uhealth ·Andrew Genz, Gregory D. Kirk, Damani A. Piggott, Shruti H. Mehta, Beth Linas, Ryan P. Westergaard	2015	31

About Ryan P. Westergaard

Ryan P. Westergaard is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Family Practice and Emergency Medicine, having authored 101 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV, Drug Use, Sexual Risk (43 papers), HIV/AIDS Research and Interventions (30 papers), Opioid Use Disorder Treatment (18 papers), Hepatitis C virus research (17 papers), Substance Abuse Treatment and Outcomes (12 papers), Hepatitis B Virus Studies (9 papers), Homelessness and Social Issues (8 papers) and Criminal Justice and Corrections Analysis (7 papers). The work is most often cited by research in Infectious Diseases (830 citations), Virology (134 citations), Epidemiology (878 citations), Hepatology (198 citations) and Modeling and Simulation (95 citations). Ryan P. Westergaard has collaborated with scholars based in United States, United Kingdom and Malaysia. Frequent co-authors include Gregory D. Kirk, Shruti H. Mehta, Anne C. Spaulding, Timothy Flanigan, Elizabeth A. Jacobs, Shawnika J. Hull, Karli R. Hochstatter, Joshua A. Barocas, John Fangman and Michael D. Repplinger. Their work appears in journals such as Harm Reduction Journal, JAMA Network Open, AIDS and Behavior, Open Forum Infectious Diseases and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact